Issue 63, 2021, Issue in Progress

Pd(ii) and Pt(ii) complexes of tridentate ligands with selective toxicity against Cryptococcus neoformans and Candida albicans

Abstract

Novel Pd(II) and Pt(II) complexes of the tridentate 2,6-bis(1-ethyl-benzimidazol-2′-yl)pyridine (LBZ), and 4′-(2-pyridyl)-2,2′:6′,2′′-terpyridine (LPY) ligands were synthesized, characterized using a variety of analytical and spectroscopic tools, and screened for their potential antimicrobial properties against some bacterial and fungal strains as well as cytotoxicity against healthy human embryonic kidney (HEK293) cells. The electronic structures of the complexes were investigated by time-dependent density functional theory calculations. The free ligand LPY and benzimidazole complexes exhibited selective toxicity against Cryptococcus neoformans and Candida albicans, while displaying no cytotoxicity against HEK293. In the case of Cryptococcus neoformans, the antifungal activities of the benzimidazole-based complexes (MIC = 1.58–2.62 μM) are higher than those of the reference drug fluconazole (26.1 μM).

Graphical abstract: Pd(ii) and Pt(ii) complexes of tridentate ligands with selective toxicity against Cryptococcus neoformans and Candida albicans

Supplementary files

Article information

Article type
Paper
Submitted
31 Aug 2021
Accepted
22 Nov 2021
First published
14 Dec 2021
This article is Open Access
Creative Commons BY-NC license

RSC Adv., 2021,11, 39748-39757

Pd(II) and Pt(II) complexes of tridentate ligands with selective toxicity against Cryptococcus neoformans and Candida albicans

A. M. Mansour, RSC Adv., 2021, 11, 39748 DOI: 10.1039/D1RA06559A

This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence. You can use material from this article in other publications, without requesting further permission from the RSC, provided that the correct acknowledgement is given and it is not used for commercial purposes.

To request permission to reproduce material from this article in a commercial publication, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party commercial publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements